These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 116622

  • 1. [Current bacteriologic and clinical aspects of chemo-antibiotic therapy of pulmonary tuberculosis].
    Saltini C, Velluti G, Mantovani P.
    Arch Monaldi; 1978; 33(4):251-79. PubMed ID: 116622
    [No Abstract] [Full Text] [Related]

  • 2. [Current bacteriologic aspects of pleuro-pulmonary tuberculosis in adults].
    Djemel A, Ladjimi S, el Askri H, Zegaya M.
    Tunis Med; 1984 Nov; 62(7):501-7. PubMed ID: 6442476
    [No Abstract] [Full Text] [Related]

  • 3. Bacteriologic basis of short-course chemotherapy for tuberculosis.
    Grosset J.
    Clin Chest Med; 1980 May; 1(2):231-41. PubMed ID: 6794976
    [No Abstract] [Full Text] [Related]

  • 4. [Clinical aspects of secondary resistance in pulmonary tuberculosis].
    Gugić B.
    Plucne Bolesti; 1985 May; 37(1-2):22-7. PubMed ID: 3934690
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical course and chemotherapy of hyperchronic destructive pulmonary tuberculosis].
    Mamolat AS, Bialik IB, Khutorskaia VD.
    Probl Tuberk; 1985 May; (10):24-8. PubMed ID: 3934660
    [No Abstract] [Full Text] [Related]

  • 6. [Chemo-antibiotic resis tance and clinicoradiologic patterns of the disease in patients with chronic pulmonary tuberculosis].
    Giura R.
    G Ital Mal Torace; 1967 May; 21(4):205-9. PubMed ID: 4970415
    [No Abstract] [Full Text] [Related]

  • 7. Treatment of tuberculosis.
    Iseman MD, Goble M.
    Adv Intern Med; 1988 May; 33():253-65. PubMed ID: 3125723
    [No Abstract] [Full Text] [Related]

  • 8. Risk factors for drug resistance in pulmonary tuberculosis inpatients.
    Yang X, Li Y, Wen X, Wu G, Li X.
    J Evid Based Med; 2010 Aug; 3(3):162-7. PubMed ID: 21349061
    [Abstract] [Full Text] [Related]

  • 9. [Primary drug resistance of Mycobacterium tuberculosis to antitubercular drugs and its clinical significance].
    Ianovskaia OM, Poliakova AN, Samuliak ID, Vasilik GV.
    Probl Tuberk; 1975 Aug; (11):69-71. PubMed ID: 815904
    [No Abstract] [Full Text] [Related]

  • 10. [Bacilliferous tuberculosis and sensitivity of Koch bacilli to tuberculostatic drugs (current situation in a French hospital service)].
    Oudet P.
    Arch Monaldi; 1972 Aug; 27(4):403-17. PubMed ID: 4217597
    [No Abstract] [Full Text] [Related]

  • 11. [Clinical and bacteriological aspects of the drug resistance of Mycobacterium tuberculosis in patients with chronic destructive pulmonary tuberculosis].
    Korotaev GA, Kozulitsyna TI, Tret'iakova EA, Mamed'iarova FA.
    Probl Tuberk; 1986 Aug; (7):32-6. PubMed ID: 3094001
    [No Abstract] [Full Text] [Related]

  • 12. [Some epidemiological and clinical aspects of primary resistance to the classic drugs in patients with pulmonary tuberculosis].
    Zierski M.
    Tuberkuloza; 1966 Aug; 18(1-3):300-6. PubMed ID: 16296101
    [No Abstract] [Full Text] [Related]

  • 13. [Drug resistance of Mycobacterium tuberculosis in patients with pulmonary tuberculosis treated in the santorium in Abastumani].
    Shilakadze EM, Margadze GKh, Zautashvili MG.
    Probl Tuberk; 1975 Aug; (3):79. PubMed ID: 124432
    [No Abstract] [Full Text] [Related]

  • 14. Difficulties in the diagnosis and treatment of drug-resistant tuberculosis and tuberculous empyema.
    Glisson J, Mehta JB.
    J Tenn Med Assoc; 1992 Sep; 85(9):419-22. PubMed ID: 1405623
    [No Abstract] [Full Text] [Related]

  • 15. [Prognostic value of isolation of drug-resistant Mycobacterium tuberculosis].
    Astionenko AA.
    Vrach Delo; 1978 Dec; (12):27-30. PubMed ID: 105475
    [No Abstract] [Full Text] [Related]

  • 16. [Toward a modern treatment of pulmonary tuberculosis. 2. Bacteriologic and pharmacologic bases and short-term treatment].
    Zegaya M.
    Tunis Med; 1984 Nov; 62(7):487-94. PubMed ID: 6442475
    [No Abstract] [Full Text] [Related]

  • 17. [Primary resistance of Mycobacterium tuberculosis. Bacteriological and epidemiological aspects].
    Nitti V.
    Arch Monaldi; 1972 Nov; 27(4):454-74. PubMed ID: 4217601
    [No Abstract] [Full Text] [Related]

  • 18. [Epidemiologic aspects of resistance to ATA (Antitubercular Agents)].
    Zrilić V, Muzikravić T.
    Plucne Bolesti Tuberk; 1974 Nov; 26 Suppl 2():29-37. PubMed ID: 4216919
    [No Abstract] [Full Text] [Related]

  • 19. [A study of prevalence of resistance to major drugs among newly admitted pulmonary tuberculosis patients in 1972. Part 2. Studies on the factors related to the prevalence of drug resistance (author's transl)].
    Gomi J, Chiba Y, Yanagisawa K.
    Kekkaku; 1975 Feb 15; 50(2):55-62. PubMed ID: 815707
    [No Abstract] [Full Text] [Related]

  • 20. [Short-course chemotherapy of pulmonary tuberculosis and several problems concerning its use, especially in India].
    Fox W.
    Bull Int Union Tuberc; 1985 Feb 15; 60(1-2):44-54. PubMed ID: 3935193
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.